Inflammatory mechanisms in neurodegeneration and Alzheimer's disease: the role of the complement system.
This review discusses key findings indicating potential roles of the complement (C)-system in chronic inflammation in Alzheimer's disease (AD) brain. Although there is no means to cure or prevent the disease, recent studies suggest that antiinflammatory drugs may delay the onset of AD dementia. One target of these drugs may be the (C)-system, which is best known for its roles in inflammatory processes in peripheral tissues. However, recent data show C-system expression and regulation in brain cells, and C-system protein deposition in AD plaques. It is still nuclear whether C-system activation contributes to neuropathology in the AD brain, as shown in multiple sclerosis (MS). New clinical studies with antiinflammatory agents are now under general consideration by the Alzheimer's Disease Cooperative Study program. In this review I outline research directions which address possible C-system contributions to neurodegeneration. Finally, I discuss potential pharmacological interventions designed to control segments of classical inflammatory cascades in which the C-system is highly implicated. These aspects are critical to the understanding of C-mediated responses in normal and pathologic brain.
Mount Sinai Medical Center, Department of Psychiatry, New York, NY 10029-6574, USA.
G M
GM
Pasinetti
D000544:Alzheimer Disease / Q000188:drug therapy / Q000473:pathology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001921:Brain / Q000473:pathology; D003165:Complement System Proteins / Q000502:physiology*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000473:pathology*; D009410:Nerve Degeneration / Q000187:drug effects / Q000502:physiology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D003165:Complement System Proteins